ER
DNA icon

Enlightenment Research’s Ginkgo Bioworks DNA Stock Holding History

Enlightenment Research’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-313
Closed -$30K – 109
2022
Q2 		$30K Buy
+313
New +$38.2K 0.06% 94
2022
Q1 		– Sell
-343
Closed -$114K – 160
2021
Q4 		$114K Buy
+343
New +$163K 0.16% 119

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Enlightenment Research's DNA Position: Q3 2022 in Review

Enlightenment Research sold out of Ginkgo Bioworks (DNA) in Q3 2022, closing a stake of 313 shares — an estimated $30K sold.

Enlightenment Research first reported a position in DNA in Q4 2021 and held it in 2 quarters. The position peaked at $114K in Q4 2021. 278 funds tracked by Wall St. Rank hold DNA as of Q3 2022.

  • Enlightenment Research reported no remaining Ginkgo Bioworks position as of Q3 2022 after selling out during the quarter.
  • Enlightenment Research sold 313 Ginkgo Bioworks shares in Q3 2022, an estimated $30K.
  • Enlightenment Research first reported a position in Ginkgo Bioworks in Q4 2021 and held it in 2 quarters.
  • Enlightenment Research's Ginkgo Bioworks position peaked at $114K in Q4 2021.
  • 278 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2022.

Based on Enlightenment Research's 13F filing for Q3 2022, filed 15 Nov 2022.